Insitu Pharma Private Limited
About Insitu Pharma Private Limited
Data last updated:
Insitu Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the basic chemical manufacturing segment of the chemicals sector. It was incorporated on 09 February 2017.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2017PTC115112.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Satyanarayana Chaduvu and Venkata Ramana Reddy Chaikam.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Flat No. 701 B Block Vertex Sadguru Krupa Hydernagar, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2018, the company reported a revenue of ₹33.04 Lakh. For the same year it recorded a net profit of ₹3,537 (net margin 0.1%) and EBITDA of ₹11,369 (EBITDA margin 0.3%).
Company details
Contact details
Insitu Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat No. 701 B Block Vertex Sadguru Krupa Hydernagar, Hyderabad, Telangana, India – 500090
- IndustryChemicals, Basic Chemical, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Insitu Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Insitu Pharma Private Limited
FY 2019 filings availableInsitu Pharma Private Limited reported revenue of ₹33.04 Lakh for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹11,369 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3,537 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.3% | |
| Net Profit Margin | 0.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Insitu Pharma Private Limited, buy the company report.
Board of directors of Insitu Pharma Private Limited
Insitu Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Chaduvu | Director | 09 Feb 2017 | 9 Years 8 Months | As last reported |
| Venkata Ramana Reddy Chaikam Also directs: Neovel Pharma Private Limited | Director | 09 Feb 2017 | 9 Years 8 Months | As last reported |
Peer comparison
Insitu Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Girgla Pharmaceuticals Private Limited | ₹33.09 Lakh (FY 2024) | -46.0% | New Delhi, Delhi, India | |||
| Kiranglobal Silicachem Private Limited | ₹33.09 Lakh (FY 2025) | 138.0% | Chennai, Tamil Nadu, India | |||
| Nano Wings Private Limited | ₹33.08 Lakh (FY 2024) | 34.0% | Khammam, Andhra Pradesh, India | |||
| Emrald Biofertilizers Private Limited | ₹33.08 Lakh (FY 2025) | 35.0% | Chennai, Tamil Nadu, India | |||
| Royal Bengal Greentech Private Limited | ₹33.04 Lakh (FY 2025) | 60.0% | Kolkata, West Bengal, India | |||
| Insitu Pharma Private Limitedthis company | ₹33.04 Lakh (FY 2018) | ₹3,537 | 0.1% | Hyderabad, Telangana, India | ||
| Glorious Healthcare Private Limited | ₹33.03 Lakh (FY 2024) | -24.0% | Indore, Madhya Pradesh, India | |||
| Mellow Pharmaceuticals Private Limited | ₹33 Lakh (FY 2022) | 17.0% | New Delhi, Delhi, India | |||
| Asolear Aesthetics Private Limited | ₹32.95 Lakh (FY 2024) | -7.0% | New Delhi, Delhi, India | |||
| Unipick Biotech Private Limited | ₹32.92 Lakh (FY 2025) | 58.0% | Indore, Madhya Pradesh, India | |||
| Nhyoda Pharmaceuticals Private Limited | ₹32.92 Lakh (FY 2023) | Pune, Maharashtra, India |
To see the full peer comparison of Insitu Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Insitu Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Insitu Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Insitu Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Insitu Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Satyanarayana Chaduvu was appointed as Director on 09 Feb 2017.
Frequently asked questions
Insitu Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Insitu Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in basic chemical, within the chemicals industry. It was incorporated on 09 February 2017 and is registered under CIN U24100TG2017PTC115112. The company has been struck off by the Registrar of Companies and is no longer operational.
Insitu Pharma had 2 directors:
- Satyanarayana Chaduvu - Director
- Venkata Ramana Reddy Chaikam - Director
The CIN (Corporate Identification Number) of Insitu Pharma is U24100TG2017PTC115112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Insitu Pharma is at Flat No. 701 B Block Vertex Sadguru Krupa Hydernagar, Hyderabad, Telangana, India – 500090.
Insitu Pharma was incorporated on 09 February 2017. It is registered with the Registrar of Companies, Hyderabad.
The latest financial statements of Insitu Pharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
Insitu Pharma operated in the chemicals industry, in the basic chemical segment. It worked in this industry before it was struck off.
The peers of Insitu Pharma by revenue are Girgla Pharmaceuticals Private Limited, Kiranglobal Silicachem Private Limited, Nano Wings Private Limited, Emrald Biofertilizers Private Limited, Royal Bengal Greentech Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satyanarayana Chaduvu was appointed as Director on 09 Feb 2017. Venkata Ramana Reddy Chaikam was appointed as Director on 09 Feb 2017.
The compliance status of Insitu Pharma is active non-compliant as of 12 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
